Matthew M.  Heeney , MD

Bunn HF, Heeney MM.

Iron Homeostasis: Deficiency and Overload. , 2010

Pathophysiology of Blood Disorders  Issue: 1st Edition (Bunn HF, Aster JC Editors) , Page: 51-62

New York: McGraw Hill

Heeney MM. Andrews NC.

Iron Homeostasis and Inherited Iron Overload Disorders: An overview. , 2004

Hematology/Oncology Clinics of North America.  Issue: 18 (6) , Page: 1379-403

Heeney MM.

Iron Deficiency Anemia: Definition, Pathophysiology and Classification. , 2011

Rudolph's Pediatrics  Issue: 22nd Edition (Rudolph AM, Rudolph C, First L, Lister G, Gershon AA. Editors) , Page: 1546-1548

New York: McGraw Hill

Heeney MM.

Anemia: Definition, Pathophysiology and Classification. , 2011

Rudolphs Pediatrics  Issue: 22nd Edition (Rudolph AM, Rudolph C, First L, Lister G, Gershon AA. Editors) , Page: 1542-1546

New York: McGraw-Hill

Heeney MM. Whorton MR. Howard TA. Johnson CA. Ware RE.

Chemical and Functional Analysis of Hydroxyurea Oral Solutions , 2004

Journal of Pediatric Hematology/Oncology  Issue: 26 (3) , Page: 179-184

Heeney MM. Howard TA. Zimmerman SA. Ware RE.

. UGT1A Promoter Polymorphisms Influence Bilirubin Response Hydroxyurea Therapy in Sickle Cell Anemia. , 2003

Journal of Laboratory and Clinical Medicine  Issue: 141 (4) , Page: 279-282

Finberg KE. Heeney MM. Campagna DR. Aydinok Y. Pearson HA. Hartman KR. Mayo MM. Samuel SM. Strouse JJ. Markianos K. Andrews NC. Fleming MD.

Mutations in TMPRSS6 cause iron-refractory iron deficiency Anemia (IRIDA). , 2008

Nature Genetics  Issue: 40 (5) , Page: 485-682

Dover GJ. Heeney MM.

Sickle Cell Disease , 2008

Nathan and Oskis Hematology of Infancy and Childhood  Issue: 7th Edition (Nathan DG, Orkin SH, Ginsburg D, Look AT. Editors) , Page: 949-1014

Philadelphia: WB Saunders

Steinberg MH. Ohene-Frempong K. Heeney MM.

Clinical and Pathophysiological Aspects of Sickle Cell Anemia. , 2009

Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (Steinberg MH, Forget BG, Higgs DR, Weatherall DJ. Editors)  Issue: 2nd Edition , Page: 437-496

Cambridge: Cambridge University Press

Heeney MM, Ware RE.

Hydroxyurea for Children with Sickle Cell Disease. , 2010

Hematology/Oncology Clinics of North America  Issue: 24 (1) , Page: 199-214

Dr. Heeney conducts clinical research focused on sickle cell disorders and their treatment. He has been the Children's Hospital Boston Principal Investigator (PI) for the Boston Comprehensive Sickle Cell Center (CSCC)and the Boston Sickle Cell Disease Research Network (SCDCRN). He is the CHB PI and for the multicenter SWiTCH and TWiTCH trials which are exploring the use of Hydroxyurea as an alternative to chronic transfusion for stroke prevention. Dr. Heeney also conducts translational research in inherited disorders of iron homeostasis in humans. In particular he is interested in investigating the genetic basis inherited disorders of iron deficiency, sideroblastic anemia and iron overload. Goals of Dr. Heeney's work include: to improve the understanding of the pathophysiology and treatment of sickle cell anemia through multicenter clinical trials and to elucidate the genetic basis of iron homeostasis and its role in human disease.

Research site for Matthew Heeney, MD

Children's Hospital Boston at Waltham